EVALUATION OF LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB THERAPY IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM BETA-CONFIDENT REGISTRY

被引：0

作者：

Kuemmerle-Deschner, J. ^{[1
]}

Hoffman, H. ^{[2
]}

Hawkins, P. ^{[3
]}

van der Poll, T. ^{[4
]}

Walker, U. ^{[5
]}

Speziale, A. ^{[6
]}

Tilson, H. ^{[7
]}

机构：

[1] Univ Hosp Tuebingen, Tubingen, Germany

[2] Univ Calif San Diego, La Jolla, CA 92093 USA

[3] UCL, Sch Med, London, England

[4] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands

[5] Univ Hosp, Basel, Switzerland

[6] Novartis Pharma AG, Basel, Switzerland

[7] Univ N Carolina, Chapel Hill, NC USA

来源：

关键词：

D O I：

10.1136/annrheumdis-2015-eular.2224

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0524

引用

页码：850 / 850

页数：1